MYERS INDUSTRIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MYERS INDUSTRIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	534	547	567	516	510	761	900	813	836	826
Cost of revenue	372	390	387	344	338	550	616	554	565	550
Gross profit	162	157	179	171	172	211	283	259	271	276
Selling, general and administrative				133	130	164	199	167	174	172
General and administrative	73.8	78.9	79.8	76.8	74
Operating income	27.4	24.9	6.33	37.3	53.6	49.3	83.9	72.4	44.5	74.6
Interest expense	9.91	8.65	6.16	4.89	4.9
Pre-tax income	18.7	15.7	1.39	33.2	48.9	45.1	78.2	66.1	13.5	45.1
Income tax	7.4	4.86	3.04	8.97	12.1	11.6	17.9	17.2	6.34	10.2
Income from continuing operations	11.3	10.8	-1.65	24.2	36.8	33.5
Net income	1.06	-9.89	-3.35	24.3	36.8	33.5	60.3	48.9	7.2	34.9
EBITDA	59.2	55.7	32.5	60.8	74.5	70.2	106	81.2	62.6	92
EPS, basic	0.03	-0.33	-0.10	0.68	1.03	0.93	1.66	1.33	0.19	0.93
EPS, diluted	0.03	-0.33	-0.10	0.68	1.02	0.92	1.64	1.32	0.19	0.93
Shares, basic (weighted)	29.8	30.2	33.4	35.5	35.8	36.1	36.4	36.7	37.1	37.4
Shares, diluted (weighted)	30	30.6	33.4	35.7	35.9	36.4	36.8	37.1	37.4	37.6
Dividend per share	0.54	0.54	0.54	0.54	0.54	0.54	0.54	0.54	0.54	0.54

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	2.4	2.52	58.9	75.5	28.3	17.7	23.1	30.3	32.2	40.5
Receivables	64.3	76.7	72.9	62.3	83.7	101	126	114	109	95.4
Inventory	44.8	47	43.6	44.3	65.9	93.6	93.4	90.8	97	67.6
Other current assets	4.64	2.2	2.53	2.83	4.76	5.5	7	6.85	8.06	6.03
Total current assets	141	150	183	185	184	220	257	257	259	281
Property, plant and equipment	106	83.9	65.5	55	74	92	102	108	138	128
Lease right-of-use assets			0	5.9	18.4	29.3	28.9	28	30.6	22.2
Goodwill	59.2	60	59.1	66.8	79.3	88.8	95.2	95.4	256	241
Intangible assets	46.9	39	30.3	30.8	41	50.2	51.8	45.1	166	146
Other non-current assets	3.31	4.15	5.71	3.9	3.56	4.24	7.92	8.36	11.3	8.23
Total assets	382	356	349	353	400	485	543	542	861	853
Accounts payable	47.6	63.6	60.8	46.9	61.2	81.7	73.5	79.1	71	51.3
Accrued liabilities	11.3	15.5	16.5
Short-term debt				0	40	0	0	26	19.6	34.6
Total current liabilities	79.3	98.7	97.4	82.6	142	133	138	165	147	169
Long-term debt	190	151	76.8	77.2	37.6	90.9	94	32	355	311
Lease liabilities			0	4.07	13.8	23.8	22.8	22.4	23.7	16.1
Other non-current liabilities	9.2	8.24	19.8	22.6	14.4	13.1	15.3	12.1	15.3	14.9
Total liabilities	289	262	194	186	211	275	286	249	583	558
Total debt	190	151	76.8	77.2	77.6	90.9	94	58	375	346
Paid-in capital	202	209	293	296	301	307	316	323	325	326
Retained earnings	-93.1	-120	-141	-135	-118	-104	-64	-35.5	-48.5	-33.9
Other comprehensive income	-34.2	-14.5	-18.3	-16.3	-15.8	-15.4	-17.8	-16.8	-22.1	-21.1
Shareholders' equity	93	93.8	155	167	189	209	256	293	278	294
Total equity	93	93.8	155	167	189	209	256	293	278	294
Total liabilities and equity	382	356	349	353	400	485	543	542	861	853
Shares outstanding	30	30.5	35.4	35.7	35.9	36.3	36.5	36.8	37.3	37.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	1.06	-9.89	-3.35	24.3	36.8	33.5	60.3	48.9	7.2	34.9
Depreciation and amortization	31.8	30.8	26.1	23.6	20.9	20.9	21.7	8.75	18.1	17.4
Stock-based compensation	3.36	3.63	4.26	1.72	3.53	3.2	7.44	6.67	1.66	3.54
Deferred income tax	0.56	-5.66	-9.45	-0.92	8.73	2.83	2.07	1.04	-6.05	3.21
Change in receivables	6.43	-6.71	4.93	12.5	-11.6	-15.3	-23.6	2.66	26.8	-11.9
Change in inventory	8.6	-1.88	3.15	2.22	-7.87	-24.9	7.96	2.63	6.23	11.4
Change in payables	-27.6	18.3	0.71	-20.7	4.66	28.1	-2.59	0.31	-22.9	8.3
Cash from operations	33.7	44.5	61.3	54.3	46.5	44.9	72.6	86.2	79.3	86.8
Capital expenditures	-12.5	-5.81	-5.12	-10.3	-13.4	-17.9	-24.3	-22.9	-24.4	-19.6
Acquisitions	0	0	0	-18	-63.3	-35.8	-27.6	-0.16	-348	0
Cash from investing	-16.1	4.14	-2.49	-20.8	-75.6	-50.3	-50.4	-22.8	-373	-18.9
Debt issued	0						0	0	400	0
Debt repaid				0	0	-40	0	0
Stock issued	3.37	4.53	2.85	3.34	1.73	3.79	2.32	2.34	3.34	1.12
Share buybacks	0	0						0	0	-2.53
Dividends paid	-16.2	-16.3	-17.9	-19.3	-19.4	-19.6	-19.8	-20.2	-20.4	-20.5
Cash from financing	-17.8	-53.7	-10.8	-17	-18.3	-5.19	-16.3	-56.5	295	-54.5
Exchange rate effect	0.67	-0.21	-0.29	0.06	0.14	-0.08	-0.44	0.25	0.05	-0.52
Net change in cash	0.06	0.14	47.7	16.6	-47.2	-10.6	5.48	7.15	1.93	12.8
Free cash flow	21.2	38.6	56.1	44	33.1	27	48.3	63.3	54.9	67.2
Interest paid	8.92	8.91	6.24	4.66	4.51	4.28	4.57	5.98	31.7	27.7
Income taxes paid	8.14	5.65	5.54	11.4	5.36	10.9	13	13.5	13	15.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $31.36 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	34.7%	Gross profit / revenue.
Operating margin	11.1%	Operating income / revenue.
EBITDA margin	13.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	7.9%	Pre-tax income / revenue.
Net margin	4.3%	Net income / revenue.
FCF margin	10.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	12.8%	Cash from operations / revenue.
Effective tax rate	23.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	12.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.3%	Net income / average total assets.
Return on invested capital (ROIC)	12.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	16.4%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.9%	Capital expenditures / revenue.
D&A / revenue	1.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-1.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-2.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	10.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	1.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	67.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-3.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	6.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	47.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-4.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	4.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	385.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-16.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-1.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	389.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-17.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-1.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	9.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	6.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	13.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	22.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	11.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	15.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	6.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	4.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	16.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	16.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.61x	Current assets / current liabilities.
Quick ratio	0.80x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.24x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.02x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	36.9%	Total debt / total assets.
Liabilities / assets	63.7%	Total liabilities / total assets.
Net debt	$264.2M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.41x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$118.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	45.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$74.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.00x	Revenue / average total assets.
Fixed asset turnover	6.85x	Revenue / average property, plant and equipment.
Inventory turnover	6.48x	Cost of revenue / average inventory.
Days inventory	56 days	365 x average inventory / cost of revenue.
Receivables turnover	7.77x	Revenue / average receivables.
Days sales outstanding	47 days	365 x average receivables / revenue.
Days payables	56 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	48 days	Days inventory + days sales outstanding - days payables.
FCF conversion	250.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	15.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.97	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$22.35	Revenue / diluted weighted shares.
FCF per share	$2.43	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.86	Cash from operations / diluted weighted shares.
Book value per share	$8.15	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1.97	Tangible book value / shares outstanding.
Cash per share	$1.27	(Cash + short-term investments) / shares outstanding.
Payout ratio	55.8%	Dividends paid / net income, when net income is positive.
Dividends / FCF	22.3%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	1.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.18B	Share price x shares outstanding.
Enterprise value	$1.44B	Market cap + total debt - cash - short-term investments.
P/E	32.2x	Market cap / net income. Only when net income is positive.
P/S	1.40x	Market cap / revenue.
P/B	3.85x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	12.9x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	10.9x	Market cap / cash from operations, when positive.
EV/Sales	1.71x	Enterprise value / revenue.
EV/EBIT	15.4x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	15.7x	Enterprise value / free cash flow, when both are positive.
FCF yield	7.8%	Free cash flow / market cap.
Earnings yield	3.1%	Net income / market cap (the inverse of P/E).
Dividend yield	1.7%	Dividends paid over the period / market cap.
Shareholder yield	1.8%	(Dividends paid + share buybacks) / market cap.

What was MYERS INDUSTRIES INC's revenue in fiscal 2025?

MYERS INDUSTRIES INC reported revenue of $825.7M for fiscal 2025, 1.3% lower than the year before.

Was MYERS INDUSTRIES INC profitable in fiscal 2025?

Yes. Net income was $34.9M, a net margin of 4.2%.

How much free cash flow did MYERS INDUSTRIES INC generate in fiscal 2025?

Cash from operations of $86.8M minus capital expenditures of $19.6M left free cash flow of $67.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to MYERS INDUSTRIES INC